Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
about
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries.Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?Molecular dynamics of class A β-lactamases-effects of substrate binding.Novel Penicillin-Type Analogues Bearing a Variable Substituted 2-Azetidinone Ring at Position 6: Synthesis and Biological Evaluation.Enzymatic deprotection of the cephalosporin 3'-acetoxy group using Candida antarctica lipase B.Design, synthesis and biological evaluation of some 2-azetidinone derivatives as potential antihyperlipidemic agents.Asymmetric synthesis of trans-β-lactams by a Kinugasa reaction on water.Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies.Access to β-lactams by enantioselective palladium(0)-catalyzed C(sp3)-H alkylation.Cycloreversion of β-lactams via photoinduced electron transfer.Ring splitting of azetidin-2-ones via radical anions.Highly diastereoselective entry into chiral spirooxindole-based 4-methyleneazetidines via formal [2+2] annulation reactionCu(i) mediated Kinugasa reactions of α,β-unsaturated nitrones: a facile, diastereoselective route to 3-(hydroxy/bromo)methyl-1-aryl-4-(-styryl)azetidin-2-onesRecent developments in the synthesis of condensed β-lactams
P2860
Q34361517-C0FCE86A-447C-4104-96E6-ABD09A246EF2Q38780854-B042DD4E-11ED-4561-8057-10A6485A6C79Q42053263-7F1A482D-F061-40B6-838A-57874EE11EFCQ42816543-CAA6D493-F23C-4EE2-9E9D-EB7BDDBDBF7FQ42911957-88748B69-ED61-4BE1-9AB7-388D479E9E7FQ43905945-F9962CCD-C6A3-4A7F-AEBE-6E13E773AD0DQ44766639-63FD54C9-AA53-41E8-AE1D-271BBE9328EBQ46489062-CF56C9F3-A7E2-4BB8-9947-81B59FF18A29Q51070606-176CB568-32FB-4118-855B-616CD48F3AC6Q53019885-A58EF8AC-6529-4792-917A-163D360DF21EQ53148958-2882D86F-9FD1-4F9F-9071-69518E76997CQ58857777-8CAB66F9-3FCD-4FA3-9B97-EB984B717C69Q58895226-4853BF4C-0A62-43A0-A453-542030EE18D3Q58895228-11015755-FA24-441F-A2C5-F87A6BD11E47
P2860
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@ast
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@en
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@nl
type
label
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@ast
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@en
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@nl
prefLabel
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@ast
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@en
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@nl
P356
P1476
Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam
@en
P2093
P304
P356
10.2174/1389557043487547
P407
P577
2004-01-01T00:00:00Z